Compare RGEN & EMBJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RGEN | EMBJ |
|---|---|---|
| Founded | 1981 | 1969 |
| Country | United States | Brazil |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Aerospace |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.0B | 12.6B |
| IPO Year | 1995 | 2006 |
| Metric | RGEN | EMBJ |
|---|---|---|
| Price | $173.57 | $74.05 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 21 | 15 |
| Target Price | ★ $203.45 | $94.80 |
| AVG Volume (30 Days) | 1.3M | ★ 1.6M |
| Earning Date | 10-27-2026 | 11-10-2026 |
| Dividend Yield | N/A | ★ 0.92% |
| EPS Growth | ★ 286.96 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $141,236,000.00 | N/A |
| Revenue This Year | $14.98 | $13.77 |
| Revenue Next Year | $26.05 | $11.17 |
| P/E Ratio | ★ N/A | $159.30 |
| Revenue Growth | ★ 35.10 | N/A |
| 52 Week Low | $100.99 | $53.56 |
| 52 Week High | $198.87 | $80.75 |
| Indicator | RGEN | EMBJ |
|---|---|---|
| Relative Strength Index (RSI) | 46.24 | 51.36 |
| Support Level | $161.15 | $71.83 |
| Resistance Level | $188.59 | $74.36 |
| Average True Range (ATR) | 8.82 | 2.66 |
| MACD | -1.00 | 0.39 |
| Stochastic Oscillator | 28.96 | 65.06 |
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, and other life science companies. It sells four main product categories: filtration and fluid management is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia-Pacific contribute about 44%, 37%, and 19% of revenue, respectively.
Embraer SA based in Sao Paulo, Brazil, manufacturer of jets. Its focus is to achieve customer satisfaction with and services addressing the commercial airline, executive jets, and defense and security markets. It has developed a customer-centric technology-driven portfolio of commercial aviation products and services that allows it to build long-term relationships with clients in the commercial aviation, executive jets, and defense and security markets. It operates through the various segments namely Commercial Aviation, Defense and Security, Executive Aviation, Service and Support, and Other Segments. The company generates maximum revenue from the Commercial Aviation segment. Geographically, the company operates in Brazil, Europe, Asia Pacific, North America, and Others.